|
PXN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51530999999983E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.3807999999943E-05 |
| Normal-vs-Stage2 |
3.394000E-02 |
| Normal-vs-Stage3 |
1.240000E-04 |
| Normal-vs-Stage4 |
3.78830000000718E-05 |
| Stage1-vs-Stage2 |
4.027800E-01 |
| Stage1-vs-Stage3 |
4.856600E-01 |
| Stage1-vs-Stage4 |
1.763630E-01 |
| Stage2-vs-Stage3 |
1.986390E-01 |
| Stage2-vs-Stage4 |
7.558300E-02 |
| Stage3-vs-Stage4 |
4.259200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78120000005055E-06 |
| Normal-vs-AfricanAmerican |
3.53360000000524E-05 |
| Normal-vs-Asian |
5.418100E-04 |
| Caucasian-vs-AfricanAmerican |
1.644610E-01 |
| Caucasian-vs-Asian |
9.939800E-01 |
| AfricanAmerican-vs-Asian |
1.939230E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.69440000000432E-05 |
| Normal-vs-Female |
1.89329999999988E-05 |
| Male-vs-Female |
9.149800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.0257000000008E-05 |
| Normal-vs-Age(41-60Yrs) |
1.24859999994786E-06 |
| Normal-vs-Age(61-80Yrs) |
4.301900E-03 |
| Normal-vs-Age(81-100Yrs) |
6.693200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.012000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.627800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.184200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.011190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.359800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.872600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.228000E-01 |
| Classical-VS-Follicular |
7.39340000333044E-09 |
| Classical-VS-Other |
3.699800E-01 |
| Classical-VS-Normal |
2.04789999957988E-07 |
| Tall-VS-Follicular |
2.979800E-04 |
| Tall-VS-Other |
2.069400E-01 |
| Tall-VS-Normal |
1.7983299999913E-05 |
| Follicular-VS-Other |
3.491600E-01 |
| Follicular-VS-Normal |
8.082400E-01 |
| Other-VS-Normal |
1.760450E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.604700E-03 |
| Normal-vs-N1 |
1.465810E-02 |
| N0-vs-N1 |
8.558600E-01 |
|
|
